Skip to content
Clinical Trials – home
Karolinska University Hospital
Sponsor

Karolinska University Hospital

Sweden Eugeniavagen 3, 171 64 Solna, Sweden

About the sponsor

Karolinska University Hospital supports clinical research across a broad range of cancer types, with particular activity in breast cancer, lung cancer, melanoma, gastrointestinal cancers, and gynaecological malignancies. Its portfolio also includes leukaemia, lymphoma, myelodysplastic syndrome, and neuroblastoma.

  • HER2-positive and HER2-low breast cancer
  • Acute myeloid leukaemia and acute lymphoblastic leukaemia
  • Follicular lymphoma and other non-Hodgkin lymphoma subtypes
  • Esophageal, gastric, pancreatic, and colorectal cancer
  • Advanced solid tumours and metastatic melanoma

Research activity also extends to molecular imaging and biomarker-driven assessment in oncology, including work focused on tumour expression profiling and treatment selection.

About Specializations

Karolinska University Hospital runs clinical trials in conditions such as Atrial fibrillation, Rheumatoid arthritis, Breast cancer, Neoplasm malignant, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

53 clinical trials

Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:SODIUM SELENITE PENTAHYDRATE
  • Sponsor:Karolinska University Hospital
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Karolinska University Hospital
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Folic Acid
  • Sponsor:Karolinska University Hospital
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Karolinska University Hospital

Cardiac arrest

Recruiting
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Levosimendan
  • Sponsor:Karolinska University Hospital
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Karolinska University Hospital
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Karolinska University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Karolinska University Hospital
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Deferoxamine Mesilate
  • Sponsor:Karolinska University Hospital
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin Propanediol
  • Sponsor:Karolinska University Hospital
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Sponsor:Karolinska University Hospital
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Cyclophosphamide
  • Sponsor:Karolinska University Hospital

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.